China Sets Aside RMB 2.7 Billion To Advance Biopharma Tech
02:00 EDT 11 Jul 2012 | Elsevier Business Intelligence
This year, China’s National Development Reform Commission has earmarked RMB 1.2 billion in funding for projects relating to development of generics and protein biopharma and vaccines.
Original Article: China Sets Aside RMB 2.7 Billion To Advance Biopharma Tech
More From BioPortfolio on "China Sets Aside RMB 2.7 Billion To Advance Biopharma Tech"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
